ICH Considerations: oncolytic viruses

Current version

PDF iconICH Considerations

Reference numberEMEA/CHMP/ICH/607698/2008
Published21/10/2009
KeywordsGene therapy, oncolytic viruses, wild type, genetically modified oncolytic viruses, manufacture, characterisation, non-clinical, clinical, biosafety
DescriptionThis document describes the general principles for the manufacturing, characterisation, non-clinical and clinical testing of medicinal products based on oncolytic viruses.


Related content


How useful was this page?

Add your rating